Saenko VA - Search Results

1

The usual ultrasonographic features of thyroid cancer are less frequent in small tumors that develop after a long latent period after the Chernobyl radiation release accident.

Drozd VM, Lushchik ML, Polyanskaya ON, Fridman MV, Demidchik YE, Lyshchik AP, Biko J, Reiners C, Shibata Y, Saenko VA, Yamashita S. Drozd VM, et al. Among authors: saenko va. Thyroid. 2009 Jul;19(7):725-34. doi: 10.1089/thy.2008.0238. Thyroid. 2009. PMID: 19445629

2

Problem of prevalence of ret/PTC rearrangements in thyroid tumors.

Saenko VA, Rogounovitch TI, Abrosimov AY, Takamura N, Lushnikov EF, Namba H, Yamashita S. Saenko VA, et al. Thyroid. 2002 May;12(5):435-6. doi: 10.1089/105072502760043549. Thyroid. 2002. PMID: 12097207 No abstract available.

3

Large deletions in mitochondrial DNA in radiation-associated human thyroid tumors.

Rogounovitch TI, Saenko VA, Shimizu-Yoshida Y, Abrosimov AY, Lushnikov EF, Roumiantsev PO, Ohtsuru A, Namba H, Tsyb AF, Yamashita S. Rogounovitch TI, et al. Among authors: saenko va. Cancer Res. 2002 Dec 1;62(23):7031-41. Cancer Res. 2002. PMID: 12460924

4

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers.

Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TI, Ohtsuru A, Saenko VA, Kanematsu T, Yamashita S. Namba H, et al. Among authors: saenko va. J Clin Endocrinol Metab. 2003 Sep;88(9):4393-7. doi: 10.1210/jc.2003-030305. J Clin Endocrinol Metab. 2003. PMID: 12970315

5

Inhibition of nuclear factor-kappaB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells.

Starenki D, Namba H, Saenko V, Ohtsuru A, Yamashita S. Starenki D, et al. J Clin Endocrinol Metab. 2004 Jan;89(1):410-8. doi: 10.1210/jc.2003-031216. J Clin Endocrinol Metab. 2004. PMID: 14715879

6

Mitochondrial DNA and human thyroid diseases.

Rogounovitch T, Saenko V, Yamashita S. Rogounovitch T, et al. Endocr J. 2004 Jun;51(3):265-77. doi: 10.1507/endocrj.51.265. Endocr J. 2004. PMID: 15256771 Free article. Review.

7

Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas.

Kumagai A, Namba H, Saenko VA, Ashizawa K, Ohtsuru A, Ito M, Ishikawa N, Sugino K, Ito K, Jeremiah S, Thomas GA, Bogdanova TI, Tronko MD, Nagayasu T, Shibata Y, Yamashita S. Kumagai A, et al. Among authors: saenko va. J Clin Endocrinol Metab. 2004 Sep;89(9):4280-4. doi: 10.1210/jc.2004-0172. J Clin Endocrinol Metab. 2004. PMID: 15356022

8

Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin.

Starenki DV, Namba H, Saenko VA, Ohtsuru A, Maeda S, Umezawa K, Yamashita S. Starenki DV, et al. Among authors: saenko va. Clin Cancer Res. 2004 Oct 15;10(20):6821-9. doi: 10.1158/1078-0432.CCR-04-0463. Clin Cancer Res. 2004. PMID: 15501958

9

The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma.

Sedliarou I, Saenko V, Lantsov D, Rogounovitch T, Namba H, Abrosimov A, Lushnikov E, Kumagai A, Nakashima M, Meirmanov S, Mine M, Hayashi T, Yamashita S. Sedliarou I, et al. Int J Oncol. 2004 Dec;25(6):1729-35. Int J Oncol. 2004. PMID: 15547711

10

A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cells.

Hayashida N, Namba H, Kumagai A, Hayashi T, Ohtsuru A, Ito M, Saenko VA, Maeda S, Kanematsu T, Yamashita S. Hayashida N, et al. Among authors: saenko va. Thyroid. 2004 Nov;14(11):910-5. doi: 10.1089/thy.2004.14.910. Thyroid. 2004. PMID: 15671769

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters